Division of Public Health, Hygiene and Epidemiology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Department of Preventive Medicine and Epidemiology, Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
Hypertens Res. 2023 Aug;46(8):1860-1869. doi: 10.1038/s41440-023-01267-1. Epub 2023 Mar 30.
Predicting and preventing new-onset chronic kidney disease (CKD) through blood pressure (BP) measurements is worthwhile. This study assessed the risk of CKD, which was defined as proteinuria and/or an estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m, according to cross-classification by systolic and diastolic BP (SBP and DBP). This retrospective population-based cohort study analyzed data from 1,492,291 participants without CKD and without antihypertensive treatment in the JMDC database, which contains the annual health check-up data of Japanese aged <75 years. During a mean follow-up of 3.2 years, CKD incidence, proteinuria, and eGFR <60 mL/min/1.73 m occurred in 92,587, 67,021, and 28,858 participants, respectively. When the SBP/DBP <120/<80 mmHg group was set as a reference, both high SBP and DBP were significantly associated with an elevated CKD risk. DBP tended to be more strongly associated with CKD risk than SBP; the hazard ratio of CKD was 1.44-1.80 in the group with SBP/DBP of 130-139/≥90 mmHg and 1.23-1.47 in the group with SBP/DBP of ≥140/80-89 mmHg. A similar result was observed for developing proteinuria and eGFR <60 mL/min/1.73 m. SBP/DBP ≥150/<80 mmHg was strongly associated with an elevated CKD risk due to the increased risk of eGFR decline. High BP, especially isolated high DBP levels, is a significant risk factor for CKD among individuals around middle age without kidney disease. Moreover, attention should be paid to kidney function, particularly eGFR decline, in the case of low DBP with extremely high SBP levels.
通过血压(BP)测量来预测和预防新发生的慢性肾脏病(CKD)是值得的。本研究评估了 CKD 的风险,CKD 定义为蛋白尿和/或估算肾小球滤过率(eGFR)<60ml/min/1.73m,根据收缩压和舒张压(SBP 和 DBP)的交叉分类。这项回顾性基于人群的队列研究分析了 JMDC 数据库中 1492291 名无 CKD 且无抗高血压治疗的参与者的数据,该数据库包含了日本<75 岁人群的年度健康检查数据。在平均 3.2 年的随访期间,92587、67021 和 28858 名参与者分别发生了 CKD 发病、蛋白尿和 eGFR<60ml/min/1.73m。当 SBP/DBP<120/<80mmHg 组作为参考时,高 SBP 和 DBP 均与 CKD 风险升高显著相关。DBP 与 CKD 风险的相关性似乎比 SBP 更强;在 SBP/DBP 为 130-139/≥90mmHg 的组中,CKD 的危险比为 1.44-1.80,在 SBP/DBP 为≥140/80-89mmHg 的组中,危险比为 1.23-1.47。对于蛋白尿和 eGFR<60ml/min/1.73m 的发展也观察到了类似的结果。SBP/DBP≥150/<80mmHg 与 CKD 风险升高显著相关,因为 eGFR 下降的风险增加。在没有肾脏疾病的中年左右人群中,BP 升高,尤其是孤立性 DBP 水平升高,是 CKD 的一个重要危险因素。此外,在 SBP 水平极高但 DBP 水平极低的情况下,应注意肾功能,特别是 eGFR 下降。